Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biomerica (BMRA) Shares Outstanding (Diluted Average) (2019 - 2026)

Biomerica's Shares Outstanding (Diluted Average) history spans 12 years, with the latest figure at $2.9 million for Q1 2026.

  • Quarterly results put Shares Outstanding (Diluted Average) at $2.9 million for Q1 2026, up 22.56% from a year ago — trailing twelve months through Feb 2026 was $2.9 million (up 22.56% YoY), and the annual figure for FY2025 was $2.3 million, up 9.22%.
  • Shares Outstanding (Diluted Average) for Q1 2026 was $2.9 million at Biomerica, down from $2.9 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $16.8 million in Q3 2023 to a low of $2.1 million in Q2 2024.
  • The 5-year median for Shares Outstanding (Diluted Average) is $12.7 million (2022), against an average of $8.8 million.
  • The sharpest move saw Shares Outstanding (Diluted Average) plummeted 87.5% in 2024, then surged 37.09% in 2025.
  • Year by year, Shares Outstanding (Diluted Average) stood at $13.5 million in 2022, then grew by 25.02% to $16.8 million in 2023, then plummeted by 87.39% to $2.1 million in 2024, then skyrocketed by 37.09% to $2.9 million in 2025, then fell by 1.93% to $2.9 million in 2026.
  • According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods came in at $2.9 million, $2.9 million, and $2.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.